Q2 2023

Filed Aug 14, 2023 · 10-Q · 45 days after period end · 0001140361-23-039358

Q2 2023 · 10-Q

Revenue

$0.00

— vs Q2 2022

Net Income

-$434.00K

N/M vs Q2 2022

EPS Diluted

-$0.05

N/M vs Q2 2022

Operating Income-$242,000N/M

Operating Cash Flow

Same quarter

Metric	Q2 2023	Q2 2022	Q2 2021	Q2 2020
Revenue	$0.00	$0.00	$0.00	$596.00K
Net Income	-$434.00K	-$1.10M	-$617.00K	$45.00K
EPS Diluted	-$0.05	-$0.14	-$0.08	$0.01

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Elite Health Systems Inc. · CIK 1089815 · Engraved from SEC EDGAR